There is currently a drug (let's call it Trepiac) on the market for a particular neurological disease. Trepiac is given once a day, is very expensive, and is of only mild benefit at best. But it's a big seller because there ain't much else out there.
Trepiac is going generic in a few years. So what is it's parent company doing? Inventing a new drug to help cure this horrible disease? F--K NO! The meeting was to consider marketing concepts for Trepiac-XR, a NEW, ONCE DAILY form of Trepiac, which is already taken once a day as is!
Sound stupid? I think so too. And this is where research dollars are being spent.